220 related articles for article (PubMed ID: 9210663)
1. Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.
Innaimo SF; Seifer M; Bisacchi GS; Standring DN; Zahler R; Colonno RJ
Antimicrob Agents Chemother; 1997 Jul; 41(7):1444-8. PubMed ID: 9210663
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.
Seifer M; Hamatake RK; Colonno RJ; Standring DN
Antimicrob Agents Chemother; 1998 Dec; 42(12):3200-8. PubMed ID: 9835515
[TBL] [Abstract][Full Text] [Related]
3. Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus.
Yamanaka G; Wilson T; Innaimo S; Bisacchi GS; Egli P; Rinehart JK; Zahler R; Colonno RJ
Antimicrob Agents Chemother; 1999 Jan; 43(1):190-3. PubMed ID: 9869593
[TBL] [Abstract][Full Text] [Related]
4. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
5. Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.
Walters KA; Tipples GA; Allen MI; Condreay LD; Addison WR; Tyrrell L
Antimicrob Agents Chemother; 2003 Jun; 47(6):1936-42. PubMed ID: 12760870
[TBL] [Abstract][Full Text] [Related]
6. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
Delaney WE; Miller TG; Isom HC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine.
Price PM; Banerjee R; Jeffrey AM; Acs G
Hepatology; 1992 Jul; 16(1):8-12. PubMed ID: 1319957
[TBL] [Abstract][Full Text] [Related]
8. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication.
Korba BE; Gerin JL
Antiviral Res; 1992 Jul; 19(1):55-70. PubMed ID: 1444322
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the replication of hepatitis B virus in vitro by a novel 2,6-diaminopurine analog, beta-LPA.
He XX; Chen T; Lin JS; Chang Y; Ye BX
Biochem Biophys Res Commun; 2008 May; 369(2):513-8. PubMed ID: 18284916
[TBL] [Abstract][Full Text] [Related]
10. Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells.
Sood RK; Bhadti VS; Fattom AI; Naso RB; Korba BE; Kern ER; Chen HM; Hosmane RS
Antiviral Res; 2002 Feb; 53(2):159-64. PubMed ID: 11750942
[TBL] [Abstract][Full Text] [Related]
11. CMCdG, a Novel Nucleoside Analog with Favorable Safety Features, Exerts Potent Activity against Wild-Type and Entecavir-Resistant Hepatitis B Virus.
Higashi-Kuwata N; Hayashi S; Das D; Kohgo S; Murakami S; Hattori SI; Imoto S; Venzon DJ; Singh K; Sarafianos SG; Tanaka Y; Mitsuya H
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670420
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosides.
Pai SB; Pai RB; Xie MY; Beker T; Shi J; Tharnish PM; Chu CK; Schinazi RF
Antivir Chem Chemother; 2005; 16(3):183-92. PubMed ID: 16004081
[TBL] [Abstract][Full Text] [Related]
14. The in vitro anti-hepatitis B virus activity of FIAU [1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell.
Staschke KA; Colacino JM; Mabry TE; Jones CD
Antiviral Res; 1994 Jan; 23(1):45-61. PubMed ID: 8141592
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatitis B virus (HBV) replication by pyrimidines bearing an acyclic moiety: effect on wild-type and mutant HBV.
Semaine W; Johar M; Tyrrell DL; Kumar R; Agrawal B
J Med Chem; 2006 Mar; 49(6):2049-54. PubMed ID: 16539393
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.
Doong SL; Tsai CH; Schinazi RF; Liotta DC; Cheng YC
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8495-9. PubMed ID: 1656445
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
Shaw T; Mok SS; Locarnini SA
Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.
Zhou YB; Wang YF; Zhang Y; Zheng LY; Yang XA; Wang N; Jiang JH; Ma F; Yin DT; Sun CY; Wang QD
Eur J Pharmacol; 2012 May; 683(1-3):10-5. PubMed ID: 22387093
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
